ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE

Size: px
Start display at page:

Download "ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE"

Transcription

1 Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 1 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE Emilia-Lidia Dumbravă (Chirilă) 1, Doina-Clementina Cojocaru 2,3, Paraschiva Postolache 2,3 University of Medicine and Pharmacy Carol Davila - Bucureşti Faculty of Medicine 1. Ph.D. student University of Medicine and Pharmacy Grigore T. Popa - Iaşi Faculty of Medicine 2.I st Medical Department Rehabilitation Clinical Hospital 3. Pulmonary Rehabilitation Clinic, Iaşi ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DYSFUNCTION IN PARKINSON S DISEASE (Abstract): Orthostatic intolerance syndrome is an important issue, having multiple etiologies and being the result of an inadequate response to changing in body position, namely the transition from supine to standing, a process that causes a series of responses regulated by the autonomic nervous system. Aim: The aim of this study was to create a profile of patients with Parkinson's disease and orthostatic hypotension, a form of orthostatic intolerance, identifying the risk factors for this condition. Material and methods: We conducted a study on 41 patients with Parkinson's disease selected from 200 consecutive patients with orthostatic hypotension, hospitalized in Cardiology Clinic of Colentina Clinic Hospital which met the diagnosis criteria for orthostatic hypotension. In order to meet the inclusion criteria, all patients were evaluated according to a preset protocol: medical history, clinical and paraclinical examination, including neuro-psychiatric assessment and the orthostatic tolerance test. Results and discussion: The decline in standing blood pressure was related to the presence of hypotensive neurological drugs, especially Levodopa, in chronic treatment, but it was not influenced by age or cardiovascular co morbidities. There is an improvement in blood pressure both in supine and upright position at discharge when compared to admission values. Conclusion: The degree of decrease in the standing blood pressure values was correlated with the presence of potentially hypotensive neurological drugs, particularly Levodopa treatment, with a favorable effect of administration of non-pharmacological treatment and changes made in chronic neurological treatment. Keywords: ORTHOSTATIC HYPOTENSION, ORTHOS- TATIC TOLERANCE TEST, PARKINSON S DISEASE. Orthostatic intolerance syndrome is an important issue, having multiple etiologies and being located on the border of several medical specialties, as diagnosis and treatment. After essential arterial hypertension, orthostatic hypotension is the most common disorder of blood pressure regulation in adults aged over 65 years, with prevalence between 5 and 30%, depending on the studied population and the used definition. 75

2 Emilia-Lidia Dumbravă (Chirilă) et al. Prospective studies have shown that orthostatic hypotension is a predictive factor for ischemic stroke and all-cause mortality in elderly people (1-3). This condition is one of the least understood manifestations of autonomic dysfunction, being the result of an inadequate response to changing in body position, namely the transition from supine to standing, a process that causes a series of responses regulated by the autonomic nervous system. The term autonomic dysfunction refers to any dysfunction of the autonomic nervous system - central, peripheral or secondary to other conditions (1,2). There are two types of autonomic dysfunction- acute and chronic form. Chronic form can be divided into primary and secondary, the last one being more common. However, when failure dominates the clinical picture and a clear cause is not obvious, it is called primary dysautonomia. Primary dysautonomia, in its turn, can be divided into four syndromes: isolated pure dysautonomia, systemic nerve atrophy, Parkinson's disease with autonomic dysfunction (3) and Lewy body dementia, while secondary autonomic dysfunction, involving autonomous damage and disease makes its debut in the context of diabetes mellitus, amyloidosis or various polyneuropathies (4-6). While primary and secondary autonomic dysfunctions are caused by structural damages of the autonomic nervous system (either central or peripheral), druginduced orthostatic hypotension is about functional impairment. The clinical aspects that suggest the diagnosis at initial assessment are represented by the onset of the symptoms (dizziness, syncope) after switching from supine to standing, possibly after prolonged immobilization and the existence of a temporal relationship between the onset and a change in dosage of potentially hypotensive drugs, parkinsonism, presence of autonomic neuropathy or hypovolemia. Effective treatment of orthostatic intolerance can be a challenge. The main therapeutic target consists of improving the symptoms in the transition from supine to standing position and functional status of the patient while reducing the risk of falls and syncope, being less oriented to strictly normalize the blood pressure levels. MATERIAL AND METHODS We conducted a study on 200 consecutive patients hospitalized in Cardiology Clinic of Colentina Clinic Hospital which met the diagnosis criteria for orthostatic hypotension as mentioned in the syncope guide of the European Society of Cardiology: a symptomatic reduction of the systolic blood pressure from baseline values with more than or equal to 20 mmhg or/and of the diastolic blood pressure with more than or equal to 10 mmhg, or a systolic pressure-lowering below 90 mmhg (3,5). To determine the blood pressure we used the active method (active standing), the orthostatic tolerance test being performed both on admission and at discharge, by measuring blood pressure and heart rate initially supine, then standing at 1, 3 and 5 minutes after changing position (4). In order to meet the inclusion criteria, all patients were evaluated according to a preset protocol: medical history, clinical and paraclinical examination, including neuro-psychiatric assessment. All the patients with Parkinson's disease were further selected in order to create a profile of these patients and to identify the risk factors for orthostatic hypotension. These neurological patients were investigated before and after non-pharmacological treatment, assessment and adjustment of the current drugs. 76

3 Orthostatic intolerance an expression of autonomic dysfunction in Parkinson s disease Statistical analyze was done using the Microsoft Excel 2007 and SPSS for Windows programs. RESULTS The larger selection group diagnosed with orthostatic intolerance (n= 200 patients) consists of 107 women and 93 men. The Parkinson s disease study group included 41 patients, the gender distribution showing a slightly higher percentage of male patients (18 men vs 13 women), representing 19.35% of total male patients and 12.15% of females (fig. 1). The mean age of neurological patients was years (64-86 years). Fig. 1. The frequency of patients depending on the presence of Parkinson's disease All the 41 Parkinson s disease patients were treated with neurological drugs, ten patients receiving also psychiatric medication, Levodopa being the most used agent in combined therapy (tab. I). Average supine blood pressure on admission was 129/75 mmhg versus 127/72 mmhg at discharge (p=0.265) (fig. 2), while the lowest of standing blood pressure values at admission was 75/40 mmhg and at discharge was reaching 90/60 mmhg (p<0.001) (fig. 3). TABLE I The distribution of cases according to the neurologicaltreatment Medication Number of cases Seligelinum 1 Amantadinum 1 Biperiden 1 Acidumvalproicum 1 Carbamazepinum 1 Rasagiline&Ropinirole 1 Amantadinum&Seligelinum 2 Fenobarbitalum&Carbamazepinum 1 Levodopa+benserazide 18 77

4 Emilia-Lidia Dumbravă (Chirilă) et al. Medication Number of cases Seligelinum&Levodopa+benserazide 4 Ropinirole&Levodopa+benserazide 1 Rasagiline&Levodopa+benserazide 1 Pramipexole&Levodopa+benserazide 1 Amantadinum&Levodopa+benserazide 1 Ropinirole& Levodopa &Carbidopa 1 Donepezile&Acidumvalproicum& Memantine&Levodopa+benserazide 1 Amantadinum&Levodopa&Carbidopa 1 Levodopa&Carbidopa&Amantadinum&Pramipexole 1 Levodopa&Carbidopa&Memantine&Pramipexole 1 Levodopa&Carbidopa&Entacapone&Amantadinum&Pramipexole 1 Total 41 Fig. 2. Average supine blood pressure values Fig. 3. Minimum of standing blood pressure values 78

5 Orthostatic intolerance an expression of autonomic dysfunction in Parkinson s disease Orthostatic tolerance test on admission revealed an average of 109/65 mmhg compared to 122/69 mmhg at discharge (p=0.007) (fig. 4). Fig. 4. Average of standing blood pressure values There was no significant difference between the mean age of patients with orthostatic hypotension and those with negative tolerance test at the time of discharge (p= 0.929). Patients with persistent orthostatic hypotension at discharge had a prevalent cardiovascular history, compared to their counterparts without orthostatic hypotension, but the difference did not reach the statistical significance (p= 0.789). All the patients received non-pharmacological treatment and 10% were treated with vasopressor agent Midodrine. Neurological medication is influencing the maintenance of orthostatic hypotension at discharge (p < 0.05), Levodopa having the most significant hypotensive effect (p < 0.001). DISCUSSION We used the analysis of postural changes in blood pressure values in order to find responsible modifiable factors that influence this type of pathology and to determine the frequencies for the studied group. It is known that in Parkinson's disease, the prevalence of orthostatic hypotension is between 43 % and 58 % and may reach up to 60 % in some studies (7). Two factors could explain this high prevalence: first, dopaminergic drugs that may induce or aggravate orthostatic hypotension, and, second, Parkinson's disease dysautonomia (8, 9). Our Parkinson s disease study group had a relatively homogenous gender distribution and a high mean value of age (76.41 years) which probably contribute to orthostatic hypotension. Also, the degree of decrease in the standing blood pressure values was correlated with the presence of potentially hypotensive neurological drugs, Levodopa being the most powerful contributor to this phenomenon, these findings being supported by several previous studies (7). Age and cardiovascular co morbidities were not influential over the presence of orthostatic intolerance, as we would have expected, but we had not perform a detailed analyze of these cardiovascular diseases and their hemodynamic effects. Despite these facts, the results showed a significant improvement of blood pressure values in both supine and upright position 79

6 Emilia-Lidia Dumbravă (Chirilă) et al. at discharge, compared to values determined on admission, for these neurological patients. This favorable outcome is even more relevant as it could not be explained by the use of vasopressors, as long as only 10% of patients were receiving Midodrine. The reasonable explanation for the improvements in blood pressure values both in supine and upright position at discharge, when compared to the values measured on admission, remains the adjustment of concomitant hypotensive medication and the association of non-pharmacological treatment, which were performed in all patients. CONCLUSIONS The results indicate that the degree of decrease in the standing blood pressure values was correlated with the presence of potentially hypotensive neurological drugs, particularly Levodopa-associating treatment. Our research also revealed that the administration of non-pharmacological treatment and changes made in chronic neurological treatment explain the favorable response to orthostatic tolerance test at discharge when compared with admission. We suggest that he management of orthostatic hypotension in patients with Parkinson's disease should always start with patient education, identification and, if possible, a change of the potential hypotensive neurologic therapy. ACKNOWLEDGEMENTS This study was financially supported by the project FEST "European Funding for Doctoral Studies" implemented by the "Carol Davila" University of Medicine and Pharmacy Bucharest-contract number POSDRU/88/1.5/S/ REFERENCES 1. Braunwald E, Bonow R, Mann D et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition, Philadelphia: Elsevier Saunders, The Consensus Comittee of the American Autonomic Society and the American Academy of Neurology.Consensus statement on the definition of orthostatic hypertension, pure autonomic failure and multiple system atrophy. Neurol 1996; 46: Goldstein DS. Cardiovascular aspects of Parkinson disease. J Neural Trans 2006; 70: Moya A, Sutton R, Ammirati F. et al. Guidelines for the diagnosis and management of syncope. Eur Heart J 2009; 30: Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neuro 2006; 13: Shibao C, Lipsitz LA, Biaggioni I. ASH Position Paper: Evaluation and Treatment of Orthostatic Hypotension. J Clin Hypertens 2013; 15: Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of orthostatic hypotension in Parkinson s disease. J Neurol Neurosurg Psychiatry 1997; 63: Fedorowski A, Stavenow L, Hedblad B et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J 2010; 31: Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging 2001; 18:

droxidopa (Northera )

droxidopa (Northera ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Treatment of orthostatic hypotension in Multiple System Atrophy New Clinical Studies

Treatment of orthostatic hypotension in Multiple System Atrophy New Clinical Studies Treatment of orthostatic hypotension in Multiple System Atrophy New Clinical Studies Cyndya A. Shibao, M.D., F.A.H.A. Assistant Professor of Medicine Division of Clinical Pharmacology Disclosure Lundbeck

More information

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension Clin Auton Res (8) 8[Suppl ]:5 9 DOI.7/s86-7-5-z ARTICLE Christopher J. Mathias L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension The European experience Received: 5 October

More information

Northera (droxidopa)

Northera (droxidopa) Northera (droxidopa) Policy Number: 5.01.657 Last Review: 07/2018 Origination: 07/2018 Next Review: 07/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Northera

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Northera) Reference Number: CP.PMN.17 Effective Date: 08.01.16 Last Review Date: 11.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy

More information

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension Clin Auton Res (2008) 18[Suppl 1]:19 24 DOI 10.1007/s10286-007-1002-2 ARTICLE Horacio Kaufmann L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension The US experience

More information

Clinical Study Nondipping in Parkinson s Disease

Clinical Study Nondipping in Parkinson s Disease SAGE-Hindawi Access to Research Parkinson s Disease Volume 2011, Article ID 897586, 5 pages doi:10.4061/2011/897586 Clinical Study Nondipping in Parkinson s Disease Sita Sommer, 1 Billur Aral-Becher, 1

More information

Središnja medicinska knjižnica

Središnja medicinska knjižnica Središnja medicinska knjižnica Adamec I., Klepac N., Milivojević I., Radić B., Habek M. (2012) Sick sinus syndrome and orthostatic hypotension in Parkinson's disease. Acta Neurologica Belgica, 112 (3).

More information

Sistema Nervoso Vegetativo Vademecum per la diagnosi differenziale

Sistema Nervoso Vegetativo Vademecum per la diagnosi differenziale Sistema Nervoso Vegetativo Vademecum per la diagnosi differenziale Pietro Cortelli IRCCS Istituto delle Scienze Neurologiche di Bologna DIBINEM, Alma Mater Studiorum - Università di Bologna Anatomo-Functional

More information

INTRODUCTION POTS is: Poorly understood Rarely considered SIGNIFICANT morbidity Appropriate initial diagnosis & care will expedite management of POTS

INTRODUCTION POTS is: Poorly understood Rarely considered SIGNIFICANT morbidity Appropriate initial diagnosis & care will expedite management of POTS Learning objectives At the end of this presentation the learner should: Define POTS & identify the various etiologies of POTS Be able to differentiate POTS from other causes of orthostatic intolerance

More information

Exercise hemodynamics in Parkinson s Disease and autonomic dysfunction

Exercise hemodynamics in Parkinson s Disease and autonomic dysfunction Exercise hemodynamics in Parkinson s Disease and autonomic dysfunction David A. Low 1,2,3*, Ekawat Vichayanrat 2,3, Valeria Iodice 2,3 and Christopher J. Mathias 2,3 1 Research Institute of Sport and Exercise

More information

Title: Is there a causal relationship between orthostatic hypotension and falling? A meta-analysis of prospective observational studies.

Title: Is there a causal relationship between orthostatic hypotension and falling? A meta-analysis of prospective observational studies. Title: Is there a causal relationship between orthostatic hypotension and falling? A meta-analysis of prospective observational studies. Alphabetical order: H.J.G. Bilo K.H. Groenier L.C. Hartog K.J.J.

More information

Managing HTN in the Elderly: How Low to Go

Managing HTN in the Elderly: How Low to Go Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular

More information

:{ic0fp'16. Geriatric Medicine: Blood Pressure Monitoring in the Elderly. Terrie Ginsberg, DO, FACOI

:{ic0fp'16. Geriatric Medicine: Blood Pressure Monitoring in the Elderly. Terrie Ginsberg, DO, FACOI :{ic0fp'16 ACOFP 53 rd Annual Convention & Scientific Seminars Geriatric Medicine: Blood Pressure Monitoring in the Elderly Terrie Ginsberg, DO, FACOI Blood Pressure Management in the Elderly Terrie B.

More information

I ngestion of water increases seated blood pressure (BP) in

I ngestion of water increases seated blood pressure (BP) in 1737 PAPER The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure T M Young, C J Mathias... See end of

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Redefining Parkinson s disease 1. Common non-motor features that precede the motor findings in Parkinson s disease (PD) include all of the following except?

More information

Blood pressure fluctuation and hypertension in patients with Parkinson s disease

Blood pressure fluctuation and hypertension in patients with Parkinson s disease Blood pressure fluctuation and hypertension in patients with Parkinson s disease Tetsuro Tsukamoto 1, Yoshimi Kitano 2 & Sadako Kuno 3 1 Department of Neurology, Numazu Rehabilitation Hospital, 2510-22

More information

Contempo GIMSI Cosa cambia alla luce della letteratura in tema di terapia farmacologica

Contempo GIMSI Cosa cambia alla luce della letteratura in tema di terapia farmacologica Contempo GIMSI 2015-2017 Cosa cambia alla luce della letteratura in tema di terapia farmacologica Dott.ssa Diana Solari Centro Aritmologico e Sincope Unit, Lavagna www.gimsi.it POST 2 (Prevention of Syncope

More information

Subject: Northera (droxidopa) Original Effective Date: 7/10/2018. Policy Number: MCP-313. Revision Date(s): Review Date: MCPC Approval Date: 7/10/2018

Subject: Northera (droxidopa) Original Effective Date: 7/10/2018. Policy Number: MCP-313. Revision Date(s): Review Date: MCPC Approval Date: 7/10/2018 Subject: Northera (droxidopa) Original Effective Date: 7/10/2018 Policy Number: MCP-313 Revision Date(s): Review Date: MCPC Approval Date: 7/10/2018 DISCLAIMER This Molina Clinical Policy (MCP) is intended

More information

Orthostatic Hypotension-Related Hospitalizations in the United States

Orthostatic Hypotension-Related Hospitalizations in the United States The American Journal of Medicine (2007) 120, 975-980 CLINICAL RESEARCH STUDY Orthostatic Hypotension-Related Hospitalizations in the United States Cyndya Shibao, MD, a Carlos G. Grijalva, MD, MPH, b Satish

More information

Identification number: TÁMOP /1/A

Identification number: TÁMOP /1/A Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master s Programmes at the University of Pécs and at the University of Debrecen Identification

More information

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension Biaggioni et al. BMC Neurology (2017) 17:90 DOI 10.1186/s12883-017-0867-5 RESEARCH ARTICLE Open Access Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension Italo Biaggioni 1*,

More information

Introduction. William Smith 1 Hong Wan. Patrick Martin 2,4

Introduction. William Smith 1 Hong Wan. Patrick Martin 2,4 Clin Auton Res (2016) 26:269 277 DOI 10.1007/s10286-016-0363-9 RESEARCH ARTICLE Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled,

More information

Tilt Table Testing MM /01/2015. HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service: Office, Outpatient

Tilt Table Testing MM /01/2015. HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service: Office, Outpatient Tilt Table Testing Policy Number: Original Effective Date: MM.02.024 01/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service:

More information

Massachusetts General Hospital Handbook of Pain Management Lippinott 2002; 350:382 In most cases of neck and back pain the anatomic and physiologic

Massachusetts General Hospital Handbook of Pain Management Lippinott 2002; 350:382 In most cases of neck and back pain the anatomic and physiologic HISTORY OF PF-NCS Massachusetts General Hospital Handbook of Pain Management Lippinott 2002; 350:382 In most cases of neck and back pain the anatomic and physiologic diagnosis remains unclear. EMG/NCV

More information

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE POTS Irritable heart syndrome. Soldier s heart. Effort syndrome. Vasoregulatory asthenia. Neurocirculatory asthenia. Anxiety neurosis.

More information

NORTHERA (droxidopa) oral capsule

NORTHERA (droxidopa) oral capsule NORTHERA (droxidopa) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements

Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements Original Article J Clin Med Res. 2018;10(4):309-313 Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements Kannayiram Alagiakrishnan a, d, Ruojin

More information

LU:research Institutional Repository of Lund University

LU:research Institutional Repository of Lund University LU:research Institutional Repository of Lund University This is an author produced version of a paper published in International journal of geriatric psychiatry. This paper has been peer-reviewed but does

More information

Prior Authorization with Quantity Limit Program Summary

Prior Authorization with Quantity Limit Program Summary Gocovri (amantadine) Prior Authorization with Quantity Limit Program Summary This prior authorization applies to Commercial, NetResults A series, SourceRx and Health Insurance Marketplace formularies.

More information

TRANSPARENCY COMMITTEE OPINION. 18 March 2009

TRANSPARENCY COMMITTEE OPINION. 18 March 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 March 2009 REQUIP LP 2 mg extended-release tablet Box of 21 tablets (CIP: 379 214-8) Box of 28 tablets (CIP: 379

More information

Compression therapy in patients with orthostatic hypotension: a systematic review

Compression therapy in patients with orthostatic hypotension: a systematic review REVIEW Compression therapy in patients with orthostatic hypotension: a systematic review H.E. Smeenk 1 *, M.J. Koster 1, R.A. Faaij 1, D.B. de Geer 2, M.E. Hamaker 1 1 Department of Geriatric Medicine,

More information

Orthostatic instability is an important co-factor and trigger of reflex syncope

Orthostatic instability is an important co-factor and trigger of reflex syncope Orthostatic instability is an important co-factor and trigger of reflex syncope Artur Fedorowski 1,2, Philippe Burri 2, Steen Juul-Möller 2, and Olle Melander 1,2 1 Lund University, Sweden 2 Skåne University

More information

Diagnosing and Treating Neurogenic Orthostatic Hypotension: A Case Study

Diagnosing and Treating Neurogenic Orthostatic Hypotension: A Case Study Diagnosing and Treating Neurogenic Orthostatic Hypotension: A Case Study Learning Objectives: Illustrate how to accurately diagnose noh Employ scales and questionnaires in combination with cardiovascular

More information

CARDIOVASCULAR DYSFUNCTION IN PARKINSONIAN DISORDERS

CARDIOVASCULAR DYSFUNCTION IN PARKINSONIAN DISORDERS CARDIOVASCULAR DYSFUNCTION IN PARKINSONIAN DISORDERS Christopher J. Mathias Neurovascular Medicine Unit, Division of Neuroscience & Psychological Medicine, Imperial College School of Medicine at St Mary

More information

Exercise Associated collapse. ACSM Team Physician Course Part II 2/4/2017 Jerrad Zimmerman MD

Exercise Associated collapse. ACSM Team Physician Course Part II 2/4/2017 Jerrad Zimmerman MD Exercise Associated collapse ACSM Team Physician Course Part II 2/4/2017 Jerrad Zimmerman MD Exercise Associated Collapse Characterized by collapse after completion of an intense exercise event in the

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart

More information

The Movement Disorders Task Force Review of Dysautonomia Rating Scales in Parkinson s Disease with Regard to Symptoms of Orthostatic Hypotension

The Movement Disorders Task Force Review of Dysautonomia Rating Scales in Parkinson s Disease with Regard to Symptoms of Orthostatic Hypotension REVIEW The Movement Disorders Task Force Review of Dysautonomia Rating Scales in Parkinson s Disease with Regard to Symptoms of Orthostatic Hypotension Anne Pavy-Le Traon, MD, PhD, 1 * Gerard Amarenco,

More information

AN INDIRECT EVALUATION OF THE NATIONAL PROGRAM OF DIABETES MELLITUS STUDY CASE OF ROMANIA

AN INDIRECT EVALUATION OF THE NATIONAL PROGRAM OF DIABETES MELLITUS STUDY CASE OF ROMANIA Rev. Med. Chir. Soc. Med. Nat., Iaşi 2013 vol. 117, no. 2 PREVENTIVE MEDICINE - LABORATORY ORIGINAL PAPERS AN INDIRECT EVALUATION OF THE NATIONAL PROGRAM OF DIABETES MELLITUS STUDY CASE OF ROMANIA Maria

More information

METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS

METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University

More information

Findings from the 2015 HRS Expert Consensus Document on Postural Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST)

Findings from the 2015 HRS Expert Consensus Document on Postural Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST) Findings from the 2015 HRS Expert Consensus Document on Postural Tachycardia Syndrome (POTS) and Inappropriate Sinus Tachycardia (IST) Ahmad Hersi, MBBS, MSc, FRCPC Professor of Cardiac Sciences Consultant

More information

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure

More information

Research Article Recurrent Syncope in Patients with Carotid Sinus Hypersensitivity

Research Article Recurrent Syncope in Patients with Carotid Sinus Hypersensitivity International Scholarly Research Network ISRN Cardiology Volume 2012, Article ID 216206, 5 pages doi:10.5402/2012/216206 Research Article Recurrent Syncope in Patients with Carotid Sinus Hypersensitivity

More information

Faculty Disclosure. Sanjay P. Singh, MD, FAAN. Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion

Faculty Disclosure. Sanjay P. Singh, MD, FAAN. Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion Faculty Disclosure Sanjay P. Singh, MD, FAAN Dr. Singh has listed an affiliation with: Consultant Sun Pharma Speaker s Bureau Lundbeck, Sunovion however, no conflict of interest exists for this conference.

More information

How to manage a patient with orthostatic hypotension

How to manage a patient with orthostatic hypotension 3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 13 How to manage a patient with autonomic dysfunction - Level 2 How to manage a patient with

More information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Overview n Brief review of Parkinson s disease (PD) n Clinical manifestations n Pathophysiology

More information

Clinical Studies 129

Clinical Studies 129 Clinical Studies 129 Syncope in migraine. The population-based CAMERA study Roland D. Thijs, 1* Mark C. Kruit, 2* Mark A. van Buchem, 2 Michel D. Ferrari, 1 Lenore J. Launer, 3,4 and J. Gert van Dijk

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST The Management of Syncope remains a challenge: Clues from the History Richard Sutton, DSc Emeritus Professor of Cardiology Imperial College, St Mary s Hospital, London,

More information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Disclosures n NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT + Learning

More information

ORIGINAL CONTRIBUTION

ORIGINAL CONTRIBUTION ORIGINAL CONTRIBUTION Orthostatic Hypotension in De Novo Parkinson Disease Ubaldo Bonuccelli, MD; Claudio Lucetti, MD; Paolo Del Dotto, MD; Roberto Ceravolo, MD; Gianna Gambaccini, MD; Silvia Bernardini,

More information

Syncope Update Dr Matthew Lovell, Consultant in Cardiology

Syncope Update Dr Matthew Lovell, Consultant in Cardiology Syncope Update Dr Matthew Lovell, Consultant in Cardiology Definition of Syncope Syncope is defined as TLOC due to cerebral hypoperfusion Characterized by a rapid onset, short duration, and spontaneous

More information

Syncope Guidelines: What s New?

Syncope Guidelines: What s New? Syncope Guidelines: What s New? Dr. Samuel Asirvatham Professor of Medicine and Pediatrics Mayo Clinic College of Medicine Medical Director, Electrophysiology Laboratory Program Director, EP Fellowship

More information

November 16-18, 2017 Hotel Monteleone New Orleans, LA. Provided by

November 16-18, 2017 Hotel Monteleone New Orleans, LA. Provided by November 16-18, 2017 Hotel Monteleone New Orleans, LA Provided by Diabetic Neuropathy: A Global and Growing Problem John D. England, MD Louisiana State University Health Sciences Center School of Medicine

More information

Note: At the end of the instructions, you will find a table which must be filled in to complete the exercise.

Note: At the end of the instructions, you will find a table which must be filled in to complete the exercise. Autonomic Nervous System Theoretical foundations and instructions for conducting practical exercises carried out during the course List of practical exercises 1. Deep (controlled) breath test 2. Cold pressor

More information

Exercise Training for PoTS and Syncope

Exercise Training for PoTS and Syncope B 140 120 100 80 60 40 20 0 Blood Pressure (mm Hg) Blood Pressure Heart Rate 60 degree Head Up Tilt Time 140 120 100 80 60 40 20 0 Heart Rate (beats.min -1 ) Exercise Training for PoTS and Syncope C Blood

More information

SYNCOPE. Sanjay P. Singh, MD Chairman & Professor, Department of Neurology. Syncope

SYNCOPE. Sanjay P. Singh, MD Chairman & Professor, Department of Neurology. Syncope SYNCOPE Sanjay P. Singh, MD Chairman & Professor, Department of Neurology. Syncope Syncope is a clinical syndrome characterized by transient loss of consciousness (TLOC) and postural tone that is most

More information

Treatment of Dysautonomia in the Joint Hypermobility Syndrome

Treatment of Dysautonomia in the Joint Hypermobility Syndrome Treatment of Dysautonomia in the Joint Hypermobility Syndrome Jaime F. Bravo, MD San Juan de Dios Hospital, Rheumatology Dept. University of Chile Medical School. Santiago, Chile Causes of Dysautonomia

More information

Healthy Aging & Clinical Care in the Elderly 2013:5

Healthy Aging & Clinical Care in the Elderly 2013:5 Open Access: Full open access to this and thousands of other papers at http://www.la-press.com. Healthy Aging & Clinical Care in the Elderly Evaluation of Systolic and Diastolic Hypotension in Dementia

More information

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy Dr Rahul Chakor, Associate Prof and Head Dept of Neurology, Dr Anand Soni, Senior Resident, T N Medical

More information

Neurogenic orthostatic hypotension: the very basics

Neurogenic orthostatic hypotension: the very basics Clin Auton Res (2017) 27:39 43 DOI 10.1007/s10286-017-0437-3 EDITORIAL Neurogenic orthostatic hypotension: the very basics Horacio Kaufmann 1 Jose-Alberto Palma 1 Received: 7 June 2017 / Accepted: 8 June

More information

Medical Conditions, Sudden Incapacitation and Assessing Syncope & Unexplained Loss of Consciousness

Medical Conditions, Sudden Incapacitation and Assessing Syncope & Unexplained Loss of Consciousness Medical Conditions, Sudden Incapacitation and Assessing Syncope & Unexplained Loss of Consciousness Kurt T. Hegmann, MD, MPH Professor and Center Director Dr. Paul S. Richards Endowed Chair in Occupational

More information

Orthostatic Hypotension

Orthostatic Hypotension Orthostatic Hypotension http://suntechmed.web4.hubspot.com/portals/41365/images/bloodpressuredoctor.jpg Orthostatic (postural) hypotension is an excessive fall in BP when an upright position is assumed.

More information

IMPROVING QUALITY OF LIFE IN ELDERLY PATIENTS WITH ORTHOSTATIC HYPOTENSION

IMPROVING QUALITY OF LIFE IN ELDERLY PATIENTS WITH ORTHOSTATIC HYPOTENSION Acta Medica Mediterranea, 2015, 31: 1001 IMPROVING QUALITY OF LIFE IN ELDERLY PATIENTS WITH ORTHOSTATIC HYPOTENSION AURELIA ROMILA, A. NECHITA, D. TUTUNARU Faculty of Medicine and Pharmacy, Dunarea de

More information

Autonomic Variation of Blood Pressure in Middle Aged Diabetics: A Prospective Study

Autonomic Variation of Blood Pressure in Middle Aged Diabetics: A Prospective Study Original Article DOI: 10.17354/ijss/2016/16 Autonomic Variation of Blood Pressure in Middle Aged Diabetics: A Prospective Study M Usharani 1, K Chandini 2 1 Professor and Head, Department of Physiology,

More information

8) BLOOD PRESSURE AND PULSE RATE RESPONSES TO SUSTAINED HANDGRIP DYNAMOMETER TEST IN RHEUMATOID ARTHRITIS PATENTS

8) BLOOD PRESSURE AND PULSE RATE RESPONSES TO SUSTAINED HANDGRIP DYNAMOMETER TEST IN RHEUMATOID ARTHRITIS PATENTS 8) BLOOD PRESSURE AND PULSE RATE RESPONSES TO SUSTAINED HANDGRIP DYNAMOMETER TEST IN RHEUMATOID ARTHRITIS PATENTS Dr. RANGRAO M. BHISE*, Dr. A.D.HATEKAR**, Dr. (Mrs.) S.D.KAUNDINYA*** *Corresponding author:

More information

Clinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy

Clinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy Original Research Article Clinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy Kothai G 1, Prasanna Karthik S 2* 1 Assistant Professor, Department of General Medicine,

More information

When an individual stands up, the autonomic

When an individual stands up, the autonomic n REPORT n Neurogenic Orthostatic Hypotension: Pathophysiology and Diagnosis Phillip A. Low, MD When an individual stands up, the autonomic nervous system ensures that adequate blood flow keeps the heart

More information

Increased all-cause mortality, total cardiovascular disease and morbidity in hospitalized elderly patients with orthostatic hypotension.

Increased all-cause mortality, total cardiovascular disease and morbidity in hospitalized elderly patients with orthostatic hypotension. Research Article http://www.alliedacademies.org/archives-of-general-internal-medicine/ Increased all-cause mortality, total cardiovascular disease and morbidity in hospitalized elderly patients with orthostatic

More information

Chronobiology in Dysautonomia and Cerebrovascular Disease

Chronobiology in Dysautonomia and Cerebrovascular Disease Progress in Clinical Medicine Chronobiology in Dysautonomia and Cerebrovascular Disease JMAJ 44(4): 171 176, 2001 Tsutomu KAMO* and Yoichi TAKAHASHI** *Assistant Professor and **Associate Professor, Department

More information

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema A.D. Margulescu 1,2, R.C. Sisu 1,2, M. Florescu 2,

More information

Cardiac Pathophysiology

Cardiac Pathophysiology Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of

More information

Journal of the American College of Cardiology Vol. 37, No. 1, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 1, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 1, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01062-7 Autonomic

More information

Banana isotonic drink improves orthostatic tolerance in voluntary dehydration subject

Banana isotonic drink improves orthostatic tolerance in voluntary dehydration subject International Food Research Journal 9 (): 88-887 (0) Banana isotonic drink improves orthostatic tolerance in voluntary dehydration subject Penggalih, M.H.S.T., Gardjito, M. and Sofro, Z.M. Nutrition and

More information

Tilt training EM R1 송진우

Tilt training EM R1 송진우 Tilt training 2006.7.15. EM R1 송진우 Introduction North American Vasovagal Pacemaker Study Randomized, controlled trial Reduction in the likelihood of syncope by dual chamber pacing with rate drop response

More information

Amantadine Extended-Release. Gocovri, Osmolex ER. Description

Amantadine Extended-Release. Gocovri, Osmolex ER. Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.21 Subject: Amantadine ER Page: 1 of 5 Last Review Date: June 22, 2018 Amantadine Extended-Release

More information

JMD. Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson s Disease ORIGINAL ARTICLE

JMD. Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson s Disease ORIGINAL ARTICLE http://dx.doi.org/10.14802/jmd.16001 / J Mov Disord 2016;9(2):97-103 pissn 2005-940X / eissn 2093-4939 ORIGINAL ARTICLE Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson s Disease Joong-Seok

More information

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner 2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current

More information

International Journal of Case Studies in Clinical Research

International Journal of Case Studies in Clinical Research Case Report Postural Tachycardia Syndrome International Journal of Case Studies in Clinical Research Open Access 1 Marieke J. Kuiper, 2 Salah A.M. Said, 3 Ali Agool 1 Medical student, University Medical

More information

F indings or symptoms of autonomic dysfunction are

F indings or symptoms of autonomic dysfunction are 1407 PAPER Age and duration related changes in muscle sympathetic nerve activity in Parkinson s disease K Shindo, H Watanabe, H Tanaka, K Ohashi, T Nagasaka, S Tsunoda, Z Shiozawa... See end of article

More information

ABSTRACT PLAIN LANGUAGE SUMMARY

ABSTRACT PLAIN LANGUAGE SUMMARY https://doi.org/10.1007/s40119-018-0124-z CASE REPORT Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and

More information

Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms

Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms J Neural Transm (2017) 124:1567 1605 DOI 10.1007/s00702-017-1791-y HIGH IMPACT REVIEW IN NEUROSCIENCE, NEUROLOGY OR PSYCHIATRY - REVIEW ARTICLE Evidence-based treatment of neurogenic orthostatic hypotension

More information

Autonomic function in a prevalent Tanzanian population with Parkinson s disease and its relationship to disease duration and 5-year mortality

Autonomic function in a prevalent Tanzanian population with Parkinson s disease and its relationship to disease duration and 5-year mortality Aris et al. BMC Research Notes 2013, 6:535 RESEARCH ARTICLE Autonomic function in a prevalent Tanzanian population with Parkinson s disease and its relationship to disease duration and 5-year mortality

More information

American Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights

American Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights American Board of Physical Medicine & Rehabilitation Part I Curriculum & Weights Neurologic Disorders 30% Stroke Spinal Cord Injury Traumatic Brain Injury Neuropathies a) Mononeuropathies b) Polyneuropathies

More information

Evaluation and Management of Orthostatic Hypotension

Evaluation and Management of Orthostatic Hypotension Evaluation and Management of Orthostatic Hypotension JEFFREY B. LANIER, MD; MATTHEW B. MOTE, DO; and EMILY C. CLAY, MD Martin Army Community Hospital Family Medicine Residency, Fort Benning, Georgia Orthostatic

More information

Resolution of Vital Sign Instability: An Objective Measure of Medical Stability in Anorexia Nervosa

Resolution of Vital Sign Instability: An Objective Measure of Medical Stability in Anorexia Nervosa JOURNAL OF ADOLESCENT HEALTH 2003;32:73 77 ORIGINAL ARTICLE Resolution of Vital Sign Instability: An Objective Measure of Medical Stability in Anorexia Nervosa TABASSUM SHAMIM, M.D., NEVILLE H. GOLDEN,

More information

Wednesday September 20 th CMT Regional Study Day. Dr Colin Mason, Consultant DME, Addenbrooke s Hospital

Wednesday September 20 th CMT Regional Study Day. Dr Colin Mason, Consultant DME, Addenbrooke s Hospital Wednesday September 20 th CMT Regional Study Day Dr Colin Mason, Consultant DME, Addenbrooke s Hospital Develop a structured approach to a patient presenting with a fall Risk stratify who can go home and

More information

Neurogenic orthostatic hypotension (NOH) results from

Neurogenic orthostatic hypotension (NOH) results from Norepinephrine Precursor Therapy in Neurogenic Orthostatic Hypotension Horacio Kaufmann, MD; Daniela Saadia, MD; Andrei Voustianiouk, PhD; David S. Goldstein, MD, PhD; Courtney Holmes, CMT; Melvin D. Yahr,

More information

Parkinson s Disease. Sirilak yimcharoen

Parkinson s Disease. Sirilak yimcharoen Parkinson s Disease Sirilak yimcharoen EPIDEMIOLOGY ~1% of people over 55 years Age range 35 85 years peak age of onset is in the early 60s ~5% of cases characterized by an earlier age of onset (typically

More information

2018 ESC Guidelines for the diagnosis and management of syncope

2018 ESC Guidelines for the diagnosis and management of syncope 2018 ESC Guidelines for the diagnosis and management of syncope Michele Brignole (Chairperson) (Italy); Angel Moya (Co-chairperson) (Spain); Jean-Claude Deharo (France); Frederik de Lange (The Netherlands);

More information

Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience

Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience KHALIL KANJWAL, M.D.,* BEVERLY KARABIN, PH.D.,* MUJEEB SHEIKH, M.D.,* LAWRENCE ELMER, M.D., PH.D., YOUSUF

More information

Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson s Disease (NOH306A)

Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson s Disease (NOH306A) Journal of Parkinson s Disease 4 (2014) 57 65 DOI 10.3233/JPD-130259 IOS Press Research Report 57 Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson s Disease (NOH306A)

More information

Dosing & Administration

Dosing & Administration Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an

More information

Evaluation of Dizziness and Fainting in Children and Adolescents

Evaluation of Dizziness and Fainting in Children and Adolescents Evaluation of Dizziness and Fainting in Children and Adolescents Collin Cowley, MD - Pediatric Cardiology Lynne Kerr, MD, PhD Pediatric Neurology Chuck Norlin, MD General Pediatrics Bettina Smith Edmondson,

More information

Hypertension and Cholesterol in the Elderly

Hypertension and Cholesterol in the Elderly Hypertension and Cholesterol in the Elderly Angela Sanford, MD Assistant Professor of Geriatrics Saint Louis University School of Medicine I have no relevant financial disclosures Cushman WC. The burden

More information

MULTI SYSTEM ATROPHY: REPORT OF TWO CASES Dipu Bhuyan 1, Rohit Kr. Chandak 2, Pankaj Kr. Patel 3, Sushant Agarwal 4, Debjanee Phukan 5

MULTI SYSTEM ATROPHY: REPORT OF TWO CASES Dipu Bhuyan 1, Rohit Kr. Chandak 2, Pankaj Kr. Patel 3, Sushant Agarwal 4, Debjanee Phukan 5 MULTI SYSTEM ATROPHY: REPORT OF TWO CASES Dipu Bhuyan 1, Rohit Kr. Chandak 2, Pankaj Kr. Patel 3, Sushant Agarwal 4, Debjanee Phukan 5 HOW TO CITE THIS ARTICLE: Dipu Bhuyan, Rohit Kr. Chandak, Pankaj Kr.

More information

Hypertension targets in the elderly. Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016

Hypertension targets in the elderly. Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016 Hypertension targets in the elderly Sarah McCracken Consultant Geriatrician North Bristol NHS Trust September 2016 NICE (2011) Aim for a target clinic blood pressure below 150/90 mmhg in people aged 80

More information

INTERNAL MEDICINE - PEDIATRICS

INTERNAL MEDICINE - PEDIATRICS Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 1 INTERNAL MEDICINE - PEDIATRICS UPDATES ANXIETY AND DEPRESSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN OPEN AGENDA FOR RESEARCH

More information

ORTHOSTATIC HYPOTENSION PREDICTS THE EARLY MORBIDITY AND MORTALITY IN PATIENTS WITH ISCHEMIC HEART DISEASE IN CORONARY CARE UNIT

ORTHOSTATIC HYPOTENSION PREDICTS THE EARLY MORBIDITY AND MORTALITY IN PATIENTS WITH ISCHEMIC HEART DISEASE IN CORONARY CARE UNIT ORTHOSTATIC HYPOTENSION PREDICTS THE EARLY MORBIDITY AND MORTALITY IN PATIENTS WITH ISCHEMIC HEART DISEASE IN CORONARY CARE UNIT Assist. Prof. Safaa Ali Khudhair F.I.C.M.S (internal medicine)* ABSTRACT

More information

FEATURE EXTRACTION AND ABNORMALITY DETECTION IN AUTONOMIC REGULATION OF CARDIOVASCULAR SYSTEM

FEATURE EXTRACTION AND ABNORMALITY DETECTION IN AUTONOMIC REGULATION OF CARDIOVASCULAR SYSTEM Proceedings of the ASME 2011 International Design Engineering Technical Conferences & Computers and Information in Engineering Conference IDETC/CIE 2011 August 28-31, 2011, Washington, DC, USA DETC2011-4

More information

Hypotensive susceptibility and antihypertensive drugs Diana Solari Santa Margherita Ligure, 7 aprile 2016

Hypotensive susceptibility and antihypertensive drugs Diana Solari Santa Margherita Ligure, 7 aprile 2016 Hypotensive susceptibility and antihypertensive drugs Diana Solari Santa Margherita Ligure, 7 aprile 2016 Arrhythmologic Center, Department of Cardiology, Lavagna SYNCOPE AND ANTIHYPERTENSIVE DRUGS Many

More information